Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs — so they don’t work well, or even at all — means new ones are urgently needed.

Antimicrobial drugs like antibiotics kill bacteria and protect humans from many deadly infections. However, bacteria are increasingly becoming resistant to these drugs, also known as Antimicrobial ...

The confluence of events that have engulfed the discovery, clinical development, and the market for antibiotics over the last two decades is evolving. And not for the better. When I first wrote ...

WEST LAFAYETTE, Ind. – A Purdue University researcher has developed a novel strategy on identifying antimicrobial drugs to better treat bacterial and fungal infections, which could produce significant ...

Millions in low- and middle-income countries could miss out on lifesaving drugs NEWS ANALYSIS | AGENCIES | Antibiotic production from big pharmaceutical companies has slowed significantly in the last ...

The antibiotic pipeline has shrunk 35 percent in five years, falling behind growing antimicrobial resistance worldwide, ...

In a recent narrative review published in the British Journal of Biomedical Science, researchers summarized the therapeutic approaches under development to tackle antimicrobial resistance (AMR).

DNA scaffolds organize silver nanoclusters into potent antimicrobials that precisely kill antibiotic-resistant bacteria, including those causing meningitis.

A biochemist professor in Nashville helped develop a groundbreaking treatment — the first new drug of its kind in three decades — to treat urinary tract infections that impact many women and some men.